Biomarker Partnership: Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
The benefits of this project include: | The benefits of this project include: | ||
This project is expected to have a significant impact on the field of biomarker research. It will make biomarker data more accessible and understandable, and it will facilitate the use of biomarkers in drug development and clinical trials. This will ultimately lead to improved personalized medicine for patients. | |||
The project will use a variety of methods to achieve its goals, including: | |||
* Data mining: The project will use data mining techniques to extract and organize biomarker data from public sources. | |||
* Software development: The project will develop software tools to support the management and analysis of biomarker data. | |||
* Training and outreach: The project will provide training and outreach materials to help researchers use the data and tools developed by the project. | |||
Latest revision as of 16:32, 12 November 2025
Biomarker Partnership is a Common Fund Data Ecosystem (CFDE) sponsored project to develop a knowledgebase that will organize and integrate biomarker data from different public sources. The data will be connected to contextual information to show a novel systems-level view of biomarkers.
The motivation for this project is to improve the harmonization and organization of biomarker data. This will be done by mapping biomarkers from public sources to, and across, CF data elements. This mapping will bridge knowledge across multiple Data Coordinating Centers (DCCs) and biomedical disciplines.
The scope of this project includes the following:
- Mapping biomarkers from public sources to relevant data elements.
- Mapping contextual data from participating DCCs.
- Developing a framework for organizing biomarker data.
- Creating tools for querying and exploring biomarker data.
- Disseminating the results of this project to the research community.
The benefits of this project include:
This project is expected to have a significant impact on the field of biomarker research. It will make biomarker data more accessible and understandable, and it will facilitate the use of biomarkers in drug development and clinical trials. This will ultimately lead to improved personalized medicine for patients.
The project will use a variety of methods to achieve its goals, including:
- Data mining: The project will use data mining techniques to extract and organize biomarker data from public sources.
- Software development: The project will develop software tools to support the management and analysis of biomarker data.
- Training and outreach: The project will provide training and outreach materials to help researchers use the data and tools developed by the project.